{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T03:37:42Z","timestamp":1760240262975,"version":"build-2065373602"},"reference-count":48,"publisher":"MDPI AG","issue":"4","license":[{"start":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T00:00:00Z","timestamp":1555286400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81673364","81501579"],"award-info":[{"award-number":["81673364","81501579"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pharmaceutics"],"abstract":"<jats:p>Azithromycin (AZI) eye drops containing sodium hyaluronate (SH) were developed to improve the bioavailability of AZI. Interaction between AZI and SH in the AZI-SH formulation was investigated by differential scanning calorimetry, X-ray diffraction, and 1H-nuclear magnetic resonance spectroscopy analyses. Moreover, advantages of using SH as an excipient were investigated by comparing physiological properties and pharmacokinetic behaviors of SH-containing AZI eye drops with that of hydroxypropyl methylcellulose (HPMC)-containing formulation. In addition, safety of the developed AZI-SH eye drops was evaluated by in vitro 3-(4,5-dimethyl-2-Thiazyl)-2, 5-diphenyl-2H-tetrazolium bromide assay (MTT assay) and neutral red uptake assay as well as in vivo eye irritation test and acute toxicity test. The results indicated that AZI formed a complex with SH under a slightly acidic condition. The area under the curve (AUC) of AZI in SH-containing formulation was 1.58-fold higher (P &lt; 0.01) than that in HPMC-containing formulation due to the interaction between the amine group of AZI and the carboxyl group of SH, despite of the higher viscosity of HPMC-containing formulation. Safety evaluation showed that AZI-SH eye drops caused no obvious eye irritation and acute toxicity. In conclusion, the developed SH-containing AZI formulation possessing advantages of longer retention time and higher drug availability was a promising drug formulation for topical ocular therapy.<\/jats:p>","DOI":"10.3390\/pharmaceutics11040183","type":"journal-article","created":{"date-parts":[[2019,4,15]],"date-time":"2019-04-15T11:15:58Z","timestamp":1555326958000},"page":"183","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":8,"title":["Preparation and Evaluation of Topically Applied Azithromycin Based on Sodium Hyaluronate in Treatment of Conjunctivitis"],"prefix":"10.3390","volume":"11","author":[{"given":"Qian","family":"Chen","sequence":"first","affiliation":[{"name":"Department of Pharmaceutics, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China"},{"name":"Center for Research Development and Evaluation of Pharmaceutical Excipients and Generic Drugs, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chun","family":"Yin","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China"},{"name":"Center for Research Development and Evaluation of Pharmaceutical Excipients and Generic Drugs, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiang","family":"Ma","sequence":"additional","affiliation":[{"name":"School of Biomedical Sciences, Faculty of Medicine, the Chinese University of Hong Kong, Hong Kong 999077, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiasheng","family":"Tu","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China"},{"name":"Center for Research Development and Evaluation of Pharmaceutical Excipients and Generic Drugs, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Shen","sequence":"additional","affiliation":[{"name":"Department of Pharmaceutics, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China"},{"name":"Center for Research Development and Evaluation of Pharmaceutical Excipients and Generic Drugs, China Pharmaceutical University, 24 Tong Jia Xiang, Nanjing 210009, China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2019,4,15]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1136\/bjo.77.2.66","article-title":"Trachoma\u2014The future for a disease of the past","volume":"77","author":"Taylor","year":"1993","journal-title":"Br. J. Ophthalmol."},{"key":"ref_2","doi-asserted-by":"crossref","unstructured":"Tung, N.T., Tran, C.S., Nguyen, T.L., Hoang, T., Trinh, T.D., and Nguyen, T.N. (2017). Formulation and biopharmaceutical evaluation of bitter taste masking microparticles containing azithromycin loaded in dispersible tablets. Eur. J. Pharm. Biopharm.","DOI":"10.1016\/j.ejpb.2017.03.017"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.epidem.2013.12.001","article-title":"The efficacy of oral azithromycin in clearing ocular chlamydia: Mathematical modeling from a community-randomized trachoma trial","volume":"6","author":"Liu","year":"2014","journal-title":"Epidemics"},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.joco.2016.08.011","article-title":"Trachoma: Past, present and future","volume":"28","author":"Mohammadpour","year":"2016","journal-title":"J. Curr. Ophthalmol."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1016\/S0140-6736(98)12387-5","article-title":"Azithromycin in control of trachoma","volume":"354","author":"Schachter","year":"1999","journal-title":"Lancet"},{"key":"ref_6","unstructured":"Solomon, A.W. (2006). Trachoma Control: A Guide for Programme Managers, World Health Organization."},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/0378-5173(90)90215-P","article-title":"Controlled drug delivery devices for experimental ocular studies with timolol 2. Ocular and systemic absorption in rabbits","volume":"61","author":"Urtti","year":"1990","journal-title":"Int. J. Pharm."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"351","DOI":"10.2165\/00003088-199937050-00001","article-title":"Treatment of Ocular Infections with Topical Antibacterials","volume":"37","author":"Leeming","year":"1999","journal-title":"Clin. Pharmacokinet."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1089\/jop.2008.0066","article-title":"Development of a topical polymeric mucoadhesive ocular delivery system for azithromycin","volume":"25","author":"Bowman","year":"2009","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1080\/03639040802680271","article-title":"Lipid emulsions as a potential delivery system for ocular use of azithromycin","volume":"35","author":"Liu","year":"2009","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.carbpol.2016.07.106","article-title":"Optimization of hyaluronan-based eye drop formulations","volume":"153","author":"Salzillo","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1136\/bjo.86.2.181","article-title":"Long term treatment with sodium hyaluronate-containing artificial tears reduces ocular surface damage in patients with dry eye","volume":"86","author":"Aragona","year":"2002","journal-title":"Br. J. Ophthalmol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1248\/cpb.55.1157","article-title":"Rheological study of binary gels with Carbopol Ultrez 10 and hyaluronic acid","volume":"55","author":"Fresno","year":"2007","journal-title":"Chem. Pharm. Bull."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S0378-5173(97)00109-9","article-title":"Functionality testing of gellan gum, a polymeric excipient material for ophthalmic dosage forms","volume":"153","author":"Rozier","year":"1997","journal-title":"Int. J. Pharm."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/jps.20612","article-title":"Microenvironmental pH modulation based release enhancement of a weakly basic drug from hydrophilic matrices","volume":"95","author":"Tatavarti","year":"2006","journal-title":"J. Pharm. Sci."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jbm.b.30613","article-title":"The elution of poly (vinyl alcohol) from a contact lens: The realization of a time release moisturizing agent\/artificial tear","volume":"80","author":"Winterton","year":"2007","journal-title":"J. Biomed. Mater. Res. B Appl. Biomater."},{"key":"ref_17","first-page":"177","article-title":"A randomized trial assessing the clinical efficacy and microbial eradication of 1% azithromycin ophthalmic solution vs tobramycin in adult and pediatric subjects with bacterial conjunctivitis","volume":"1","author":"Abelson","year":"2007","journal-title":"Clin. Ophthalmol."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"3425","DOI":"10.1167\/iovs.06-1413","article-title":"Phase 3 safety comparisons for 1.0% azithromycin in polymeric mucoadhesive eye drops versus 0.3% tobramycin eye drops for bacterial conjunctivitis","volume":"48","author":"Protzko","year":"2007","journal-title":"Investig. Ophthalmol. Vis. Sci."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1016\/j.carbpol.2016.06.101","article-title":"Fabrication of a bioadhesive transdermal device from chitosan and hyaluronic acid for the controlled release of lidocaine","volume":"152","author":"Anirudhan","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ijbiomac.2016.04.070","article-title":"Development of chitosan nanoparticles coated with hyaluronic acid for topical ocular delivery of dexamethasone","volume":"89","author":"Kalam","year":"2016","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.msec.2014.01.052","article-title":"Chemical functionalization of hyaluronic acid for drug delivery applications","volume":"38","author":"Vasi","year":"2014","journal-title":"Mater. Sci. Eng. C Mater. Biol. Appl."},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0886-3350(13)80903-0","article-title":"Evidence of hyaluronic acid and hyaluronic acid binding sites on human corneal endothelium","volume":"18","author":"Molander","year":"1992","journal-title":"J. Cataract. Refract. Surg."},{"key":"ref_23","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.4103\/0366-6999.164927","article-title":"Therapeutic Effects of Sodium Hyaluronate on Ocular Surface Damage Induced by Benzalkonium Chloride Preserved Anti-glaucoma Medications","volume":"128","author":"Liu","year":"2015","journal-title":"Chin. Med. J."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.ejps.2008.04.006","article-title":"In vitro modulation of preservative toxicity: High molecular weight hyaluronan decreases apoptosis and oxidative stress induced by benzalkonium chloride","volume":"34","author":"Pauloin","year":"2008","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_25","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1016\/j.exer.2013.10.005","article-title":"Bilateral acute pyogenic conjunctivitis with iritis induced by unilateral topical application of bacterial peptidoglycan muramyl dipeptide in adult rabbits","volume":"116","author":"Langford","year":"2013","journal-title":"Exp. Eye Res."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/jop.1997.13.151","article-title":"Tear film stability of protein extracts from dry eye patients administered a sigma agonist","volume":"13","author":"Schoenwald","year":"1997","journal-title":"J. Ocul. Pharmacol. Ther."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/S0039-6257(01)00211-9","article-title":"The Draize eye test","volume":"45","author":"Wilhelmus","year":"2001","journal-title":"Surv. Ophthalmol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.toxlet.2009.09.007","article-title":"Assessment of the dermal and ocular irritation potential of multi-walled carbon nanotubes by using in vitro and in vivo methods","volume":"191","author":"Kishore","year":"2009","journal-title":"Toxicol. Lett."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ejps.2014.05.020","article-title":"Proniosome-derived niosomes for tacrolimus topical ocular delivery: In vitro cornea permeation, ocular irritation, and in vivo anti-allograft rejection","volume":"62","author":"Li","year":"2014","journal-title":"Eur J. Pharm. Sci."},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1016\/j.biomaterials.2006.11.028","article-title":"Ocular drug delivery by liposome-chitosan nanoparticle complexes (LCS-NP)","volume":"28","author":"Diebold","year":"2007","journal-title":"Biomaterials"},{"key":"ref_31","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.ijpharm.2010.05.043","article-title":"High azithromycin loading powders for inhalation and their in vivo evaluation in rats","volume":"395","author":"Zhang","year":"2010","journal-title":"Int. J. Pharm."},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1016\/j.nano.2017.05.001","article-title":"Ion-paired pirenzepine-loaded micelles as an ophthalmic delivery system for the treatment of myopia","volume":"13","author":"Li","year":"2017","journal-title":"Nanomedicine"},{"key":"ref_33","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.ijpharm.2012.11.040","article-title":"Pharmaceutical development and optimization of azithromycin suppository for paediatric use","volume":"441","author":"Kauss","year":"2013","journal-title":"Int. J. Pharm."},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.carbpol.2016.05.104","article-title":"Formation and properties of hyaluronan\/nano Ag and hyaluronan-lecithin\/nano Ag films","volume":"151","author":"Khachatryan","year":"2016","journal-title":"Carbohydr. Polym."},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/0378-5173(96)04525-5","article-title":"Rheological evaluation and ocular contact time of some carbomer gels for ophthalmic use","volume":"137","author":"Edsman","year":"1996","journal-title":"Int. J. Pharm."},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.ejps.2014.07.013","article-title":"Preparation and in vitro-in vivo evaluation of ofloxacin loaded ophthalmic nano structured lipid carriers modified with chitosan oligosaccharide lactate for the treatment of bacterial keratitis","volume":"63","author":"Ozer","year":"2014","journal-title":"Eur. J. Pharm. Sci."},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/0378-5173(89)90328-1","article-title":"The evaluation of viscous ophthalmic vehicles by slit lamp fluorophotometry in humans","volume":"54","author":"Ludwig","year":"1989","journal-title":"Int. J. Pharm."},{"key":"ref_38","unstructured":"Parrott, E.L. (1970). Pharmaceutical Technology: Fundamental Pharmaceutics, Burgess Pub. Co."},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S1474-6670(17)66563-7","article-title":"Non-Linear Time Series Model Identification by Akaike\u2019s Information Criterion","volume":"10","author":"Ozaki","year":"1977","journal-title":"IFAC Proc. Vol."},{"key":"ref_40","doi-asserted-by":"crossref","first-page":"755","DOI":"10.3109\/03639049009114907","article-title":"Rheological Characterization of Tear Substitutes","volume":"16","author":"Bother","year":"2008","journal-title":"Drug Dev. Ind. Pharm."},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/0378-5173(94)00389-M","article-title":"Influence of molecular weight and formulation pH on the precorneal clearance rate of hyaluronic acid in the rabbit eye","volume":"118","author":"Durrani","year":"1995","journal-title":"Int. J. Pharm."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/0169-409X(95)00013-W","article-title":"Bioadhesive and phase-change polymers for ocular drug delivery","volume":"16","author":"Robinson","year":"1995","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/0022-1759(86)90368-6","article-title":"Rapid colorimetric assay for cell growth and survival. Modifications to the tetrazolium dye procedure giving improved sensitivity and reliability","volume":"89","author":"Denizot","year":"1986","journal-title":"J. Immunol. Methods"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/0378-4274(85)90046-3","article-title":"Toxicity determined in vitro by morphological alterations and neutral red absorption","volume":"24","author":"Borenfreund","year":"1985","journal-title":"Toxicol. Lett."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1016\/S1542-0124(12)70195-7","article-title":"In Vitro Alternatives to the Use of Animals in Ocular Toxicology Testing","volume":"3","author":"Ubels","year":"2005","journal-title":"Ocul. Surf."},{"key":"ref_46","doi-asserted-by":"crossref","first-page":"117","DOI":"10.4265\/bio.16.117","article-title":"Cell viability of four corneoconjunctival cell lines exposed to five preservatives and a surfactant used for infection control in eyedrops","volume":"16","author":"Ayaki","year":"2011","journal-title":"Biocontrol Sci."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.yrtph.2013.03.014","article-title":"Cell viability score (CVS) as a good indicator of critical concentration of benzalkonium chloride for toxicity in cultured ocular surface cell lines","volume":"66","author":"Iwasawa","year":"2013","journal-title":"Regul. Toxicol. Pharmacol."},{"key":"ref_48","first-page":"3364","article-title":"Genoprotective effect of hyaluronic acid against benzalkonium chloride-induced DNA damage in human corneal epithelial cells","volume":"17","author":"Wu","year":"2011","journal-title":"Mol. Vis."}],"container-title":["Pharmaceutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1999-4923\/11\/4\/183\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T12:45:40Z","timestamp":1760186740000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1999-4923\/11\/4\/183"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,15]]},"references-count":48,"journal-issue":{"issue":"4","published-online":{"date-parts":[[2019,4]]}},"alternative-id":["pharmaceutics11040183"],"URL":"https:\/\/doi.org\/10.3390\/pharmaceutics11040183","relation":{},"ISSN":["1999-4923"],"issn-type":[{"type":"electronic","value":"1999-4923"}],"subject":[],"published":{"date-parts":[[2019,4,15]]}}}